Targeting cancerous vessels

Targeting cancerous vessels
Vascular endothelial cells (green) express {delta}-catenin (red). Credit: DeBusk, L.M., et al. 2010. J. Exp. Med. doi:10.1084/jem.20091097

By lowering the level of a neuronal protein, researchers halted the growth of blood vessels that tumors rely on for survival. The findings are reported online in the Journal of Experimental Medicine on Jan. 4.

Formerly known for its effects on neuronal growth, the team found that the protein {delta}-catenin is also produced by in human blood vessels. By diminishing {delta}-catenin expression, the team disrupted vessel development, or angiogenesis, associated with in tumors and wounds. As expected, samples of human lung tumors expressed more {delta}-catenin than the surrounding tissues. And normal angiogenesis remained the same regardless of {delta}-catenin.

Because blocking {delta}-catenin stunts only inflammation-induced angiogenesis, the may be a promising anti-cancer target, says Charles Lin, an author on the study at Vanderbilt University Medical Center in Tennessee.


Explore further

Enzyme Eliminated by Cancer Cells Holds Promise for Cancer Treatment

More information: DeBusk, L.M., et al. 2010. J. Exp. Med. doi:10.1084/jem.20091097
Citation: Targeting cancerous vessels (2010, January 4) retrieved 27 February 2021 from https://medicalxpress.com/news/2010-01-cancerous-vessels.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.
 shares

Feedback to editors

User comments